Literature DB >> 10541874

Variant Gerstmann-Sträussler syndrome with the P105L prion gene mutation: an unusual case with nigral degeneration and widespread neurofibrillary tangles.

M Yamazaki1, K Oyanagi, O Mori, S Kitamura, M Ohyama, A Terashi, T Kitamoto, Y Katayama.   

Abstract

We present here a case of variant Gerstmann-Sträussler syndrome (GSS) with a codon 105 mutation of the prion protein gene. A 57-year-old woman developed dementia and gait disturbance dissimilar to the spastic paraparesis that is observed in most cases with codon 105 mutation. The clinical course of the disease in this case was 12 years. The brain weighed 900 g, and the frontal lobe, pallidum and thalamus were markedly atrophic. Severe neuronal loss was observed in the deep layer of the frontal and temporal cortices, and fibrillary gliosis and a marked loss of neurons was observed in the globus pallidus, thalamus and substantia nigra. Many amyloid plaques and some ballooned neurons were present in the frontal, temporal and parietal cortices. However, no spongiform changes were seen. The cerebellum was relatively well preserved. Numerous neurofibrillary tangles (NFTs) were recognized in the cerebral cortices, and scattered NFTs were observed in the basal nucleus of Meynert, thalamus, substantia nigra, periaqueductal gray matter, raphe nuclei and locus ceruleus. The case presented here indicates the presence of variations in the pathological findings of cases with codon 105 mutation, and that the formation of cortical and brain stem NFTs might have something to do with the duration of illness and/or the degree of brain tissue destruction that had occurred.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10541874     DOI: 10.1007/s004010051116

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  12 in total

1.  Specific amyloid-β42 deposition in the brain of a Gerstmann-Sträussler-Scheinker disease patient with a P105L mutation on the prion protein gene.

Authors:  Fumiko Furukawa; Nobuo Sanjo; Atsushi Kobayashi; Tsuyoshi Hamaguchi; Masahito Yamada; Tetsuyuki Kitamoto; Hidehiro Mizusawa; Takanori Yokota
Journal:  Prion       Date:  2018-11-13       Impact factor: 3.931

2.  Gerstmann-Sträussler-Scheinker Disease Presenting with Atypical Parkinsonism, but Typical Magnetic Resonance Imaging Findings of Prion Disease.

Authors:  Roser Ribosa-Nogué; Javier Pagonabarraga; Beatriz Gomez-Anson; Esther Granell-Moreno; Raquel Sánchez-Valle; Jaime Kulisevsky
Journal:  Mov Disord Clin Pract       Date:  2015-09-06

3.  Alzheimer's disease-causing proline substitutions lead to presenilin 1 aggregation and malfunction.

Authors:  Tziona Ben-Gedalya; Lorna Moll; Michal Bejerano-Sagie; Samuel Frere; Wayne A Cabral; Dinorah Friedmann-Morvinski; Inna Slutsky; Tal Burstyn-Cohen; Joan C Marini; Ehud Cohen
Journal:  EMBO J       Date:  2015-10-05       Impact factor: 11.598

4.  Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases.

Authors:  Giuseppe Legname; Tommaso Virgilio; Edoardo Bistaffa; Chiara Maria Giulia De Luca; Marcella Catania; Paola Zago; Elisa Isopi; Ilaria Campagnani; Fabrizio Tagliavini; Giorgio Giaccone; Fabio Moda
Journal:  Prion       Date:  2018-05-18       Impact factor: 3.931

5.  Context dependent neuroprotective properties of prion protein (PrP).

Authors:  Andrew D Steele; Zhipeng Zhou; Walker S Jackson; Chunni Zhu; Pavan Auluck; Michael A Moskowitz; Marie-Francoise Chesselet; Susan Lindquist
Journal:  Prion       Date:  2009-10-16       Impact factor: 3.931

6.  Scrapie-like prion protein accumulates in aggresomes of cyclosporin A-treated cells.

Authors:  Ehud Cohen; Albert Taraboulos
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

Review 7.  Monoaminergic neuropathology in Alzheimer's disease.

Authors:  Goran Šimić; Mirjana Babić Leko; Selina Wray; Charles R Harrington; Ivana Delalle; Nataša Jovanov-Milošević; Danira Bažadona; Luc Buée; Rohan de Silva; Giuseppe Di Giovanni; Claude M Wischik; Patrick R Hof
Journal:  Prog Neurobiol       Date:  2016-04-12       Impact factor: 11.685

Review 8.  The Emerging Roles of Early Protein Folding Events in the Secretory Pathway in the Development of Neurodegenerative Maladies.

Authors:  Tatyana Dubnikov; Ehud Cohen
Journal:  Front Neurosci       Date:  2017-02-07       Impact factor: 4.677

9.  iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology.

Authors:  Andreu Matamoros-Angles; Lucía Mayela Gayosso; Yvonne Richaud-Patin; Angelique di Domenico; Cristina Vergara; Arnau Hervera; Amaya Sousa; Natalia Fernández-Borges; Antonella Consiglio; Rosalina Gavín; Rakel López de Maturana; Isidro Ferrer; Adolfo López de Munain; Ángel Raya; Joaquín Castilla; Rosario Sánchez-Pernaute; José Antonio Del Río
Journal:  Mol Neurobiol       Date:  2017-05-02       Impact factor: 5.590

10.  Atypical parkinsonism caused by Pro105Leu mutation of prion protein: A broad clinical spectrum.

Authors:  Kagari Koshi Mano; Takashi Matsukawa; Jun Mitsui; Hiroyuki Ishiura; Shin-Ichi Tokushige; Yuji Takahashi; Naoko Saito Sato; Fumiko Kusunoki Nakamoto; Yaeko Ichikawa; Yu Nagashima; Yasuo Terao; Jun Shimizu; Masashi Hamada; Yoshikazu Uesaka; Genko Oyama; Go Ogawa; Jun Yoshimura; Koichiro Doi; Shinichi Morishita; Shoji Tsuji; Jun Goto
Journal:  Neurol Genet       Date:  2016-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.